Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 32 holding rows worth $505,716,000.

Accession
0001085146-22-002187
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 32 entries on the cover page, a total value of $505,716,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $505,718,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM2,061,402$244,420,000thousands by filing date
QUIDEL CORP74838J101COM708,631$79,693,000thousands by filing date
OPKO HEALTH INC68375N103COM8,985,756$30,911,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,720,733$27,979,000thousands by filing date
AGENUS INC00847G705COM NEW8,706,132$21,417,000thousands by filing date
ARK ETF TR00214Q104INNOVATION ETF250,000$16,573,000thousands by filing date
SEMA4 HOLDINGS CORP81663L101COM3,944,832$12,111,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,225,395$11,151,000thousands by filing date
DERMTECH INC24984K105COM652,907$9,585,000thousands by filing date
FORIAN INC34630N106cs1,262,040$8,784,000thousands by filing date
CONTRAFECT CORP212326300COM1,954,222$7,133,000thousands by filing date
ANTARES PHARMA INC036642106COM1,720,000$7,052,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM186,789$4,524,000thousands by filing date
Accelerate Diagnostics00430H102COM2,731,856$3,934,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM504,602$3,164,000thousands by filing date
IMMUTEP LTD45257L108SPONSORED ADS976,156$2,675,000thousands by filing date
IMMUNITYBIO INC45256X103COM400,013$2,244,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM2,116,839$2,202,000thousands by filing date
DIREXION DAILY S&P BIOTECH BULL 3X ETF25490K323ETF1,000,000$1,775,000thousands by filing dateput
CENTENE CORP DEL COM15135B101Stock300,000$1,485,000thousands by filing dateput
Pfizer Inc.717081103COM550,000$1,265,000thousands by filing dateput
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock550,000$1,263,000thousands by filing dateput
ACADIA PHARMACEUTICALS INC004225108COM459,300$1,058,000thousands by filing dateput
DERMTECH INC24984K105COM193,800$921,000thousands by filing dateput
VERTEX ENERGY INC92534K107COM55,000$547,000thousands by filing date
BIOGEN INC COM09062X103Stock2,412$508,000thousands by filing date
SOLENO THERAPEUTIVS, INC.834203200COMM2,132,000$475,000thousands by filing date
OPKO HEALTH INC68375N103COM749,900$292,000thousands by filing dateput
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM20,000$212,000thousands by filing dateput
QUIDEL CORP74838J101COM26,500$200,000thousands by filing dateput
Arbutus Biopharma Corp03879J100Common Shares, without par value50,000$149,000thousands by filing date
PROTAGENIC THERAPEUTICS INC74365N103COM20,000$16,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-22-002187this filing2022-05-16acceptance time not in the bulk data set